3.3. Effects on the Selected Biomarkers of the Intervention with Selenium and Coenzyme Q
At inclusion, no difference in the concentration of ICAM-1 was found between the active treatment and the placebo groups (0.183 µg/mL vs. 0.178 µg/mL; Validating the obtained results through an ANCOVA, it is obvious that only the active treatment and the ICAM-1 concentration at inclusion significantly influenced the result (